archive-com.com » COM » E » ENDEAVOURVISION.COM

Total: 462

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Endeavour Vision - Portfolio
    as an outsourced solution to operators Sold to Phone com in October 2000 became Openwave OPWV Indications of stroke and the related indications neuronal damage and thrombotic disease IPO on Frankfurt exchange PA8 in February 2005 Perigee Software Suite provides companies multi channel publishing of all product information PneumRx is developing and marketing minimally invasive therapeutic devices to treat emphysema patients Software testing and debugging for embedded applications Sold to Mathworks US in April 2007 Retailo is the leading European pre paid and gift card malls operator with more than 20 000 point of sales in five countries Flash memory semiconductor and products Nasdaq IPO in November 1995 Electronic Catalogue and sales configuration software for e commerce Sold to PartRiver in 2006 Conditional access security systems for encryption payment and data storage SCM went public at end 1997 in a dual listing on the Nasdaq and the Neuer Markt Seatex is a GPS System for mapping shipping and offshore undustry IPO on the Olslo Exchange in January 1994 NYSE SQNS 4G chipmaker supplying LTE and WiMAX chipsWiMax wireless broadband chipsets and software solutions Real time fault detection and classification solutions for the semiconductor industry Tunable lasers for telecom and sensing applications Acquired by Ignis in April 2009 Develop manufacture and market dental implant systems Sold participation in January 2006 Powerline signal transmission solution Transaction reconciliation software and payment infrastructure solutions Nasdaq IPO in Spetember 1999 Provider of engineering design development and manufacturing services for the medical device and select industrial markets Veebeam is the easiest most affordable way to wirelessly stream anything from your laptop to your TV High performance semiconductor and integrated comminication software for DSL networks Nasdaq IPO in November 1999 High performance virtual systems symulation Companie sold to Wind River Intel in February 2010 Revenue assurance solution for Telecom Operators Company was sold to Martin Dawes Systems UK in 2005 Automotive parts Reg S sold participation in October 1993 Indication for pulmonary arterial hypertension PAH a life threatening disorder which severely compromises the function of the lungs and heart IPO on SWX in April 2000 Tunable lasers for telecom networks Sold to ADC Telecommunications ADCT in May 2000 Unbreakable energy efficient and scalable storage solution for cloud computing Voice command and recognition solution Sold to Fonix FONX in July 1998 Software data backup and restore enterprise solution Telecom Datacom software for managing broadband networks Sold to Cisco CSCO in May 1999 Digital rights management for music on Internet IP sold to Macrovision MVSN in June 2002 Optical components vertical cavity lasers VCSEL for datacom and sensing applications Sold to Bookham BKHM in March 2006 Founded in April 2000 Discovery and development of small molecules active on novel G protein coupled receptors CHF38 Mio raised 60 employees Most advanced project Phase II sub arachnoid haemorrhage Acquired by Actelion ATLN in October 2003 Bind Therapeutics BIND is a biopharmaceutical company developing therapeutic targeted nanoparticles Imaging and analysis software for life science applications Company sold to Andor Technology in December 2009 Optical Switch Optical Character Recognition OCR Sold to Caere US in December 1994 Caere subsequently merged with Scansoft then Nuance Medical Technology company developing a device to improve the care of type 2 diabetic patients CMOS analog semiconductor chipset IP and services The company was acquired by MIPS Technologies on Aug 27 2007 Softswitches provider for Telecoms Operators Sold to Thomson in April 2005 CommProve is a provider of advanced solutions for real time monitoring of wireless networks Multifactor authentication and identification solutions combining biometrics PKI smart cards and pin code Web based on demand collaborative business software Optical Components Dynamic Gain Equalized Dynamic Add Drop Multiplexor based in a unique polymer dispersed liquid crystal process High performance interconnection bus Sold participation in November 1996 Medical technology company with a device to treat morbid obese patients A gastric band restricts food intake and is remotely controlled by the medical doctor Company sold to Allergan AGN in February 2007 Discovery and development of SGDs small glycan drugs to provide the patient with safer and more efficient anti thrombotics Internet tools for business analysis Voice and Video over IP software Flamentera is developing monitoring tests for celiac disease Fully automated system for molecular biology diagnostics enabling easy DNA extraction and fast detection of bacteria Gynesonics designs and develops new and advanced technologies for improving women s health The company is focused on providing to women and the physicians who care for them an incision free uterus preserving option to treat symptomatic uterine fibroids The Sonata system combines intrauterine sonography with radio frequency ablation to precisely locate and ablate uterine fibroids associated with heavy menstrual symptoms in a simple same day procedure The system is cleared for sale in Europe CE Mark and the company is currently enrolling its US pivotal trial to evaluate safety and effectiveness Sonata offers the potential to reduce the number of more invasive procedures including hysterectomy and to offer women greater choices in the treatment of this very common condition Harbor Software database tools Telecommunication service creation platform Enterprise knowledge management solution Software editor in France and one of the leaders in Europe in the social gaming universe on Facebook and mobiles Biomaterials and bioactives for chronic wounds and bone regeneration Lumavita is a biotech pharma company based in Basel Switzerland specialising in Woman s Health Content Management solution for digital TV operators content providers and broadcasters Web application development platform Sold to BEA in November 2005 Gigabit Ethernet chipset Sold to Agere AGRA in November 2003 Technical calculation software for applying mathematics to engineering Nasdaq IPO in February 1993 Supplier of high precision reflective optical components and systems using a unique electroforming process Analytical Instrumentation Mobile content distribution platform and services Sold to Alcatel in 2004 Molecular Partners is developing a novel class of binding proteins DARPins that will compete with monoclonal antibodies by addressing some of their weaknesses Mobile payment solution Advance motion technology to build linear actuators that are silent low cost and low

    Original URL path: http://www.endeavourvision.com/portfolio-9-home.htm (2016-04-25)
    Open archived version from archive


  • Investments in technology
    markets Veebeam is the easiest most affordable way to wirelessly stream anything from your laptop to your TV High performance semiconductor and integrated comminication software for DSL networks Nasdaq IPO in November 1999 High performance virtual systems symulation Companie sold to Wind River Intel in February 2010 Revenue assurance solution for Telecom Operators Company was sold to Martin Dawes Systems UK in 2005 Automotive parts Reg S sold participation in October 1993 Tunable lasers for telecom networks Sold to ADC Telecommunications ADCT in May 2000 Unbreakable energy efficient and scalable storage solution for cloud computing Voice command and recognition solution Sold to Fonix FONX in July 1998 Software data backup and restore enterprise solution Telecom Datacom software for managing broadband networks Sold to Cisco CSCO in May 1999 Digital rights management for music on Internet IP sold to Macrovision MVSN in June 2002 Optical components vertical cavity lasers VCSEL for datacom and sensing applications Sold to Bookham BKHM in March 2006 Imaging and analysis software for life science applications Company sold to Andor Technology in December 2009 Optical Switch Optical Character Recognition OCR Sold to Caere US in December 1994 Caere subsequently merged with Scansoft then Nuance CMOS analog semiconductor chipset IP and services The company was acquired by MIPS Technologies on Aug 27 2007 Softswitches provider for Telecoms Operators Sold to Thomson in April 2005 CommProve is a provider of advanced solutions for real time monitoring of wireless networks Multifactor authentication and identification solutions combining biometrics PKI smart cards and pin code Web based on demand collaborative business software Optical Components Dynamic Gain Equalized Dynamic Add Drop Multiplexor based in a unique polymer dispersed liquid crystal process High performance interconnection bus Sold participation in November 1996 Internet tools for business analysis Voice and Video over IP software Harbor Software database tools Telecommunication service creation platform Enterprise knowledge management solution Software editor in France and one of the leaders in Europe in the social gaming universe on Facebook and mobiles Content Management solution for digital TV operators content providers and broadcasters Web application development platform Sold to BEA in November 2005 Gigabit Ethernet chipset Sold to Agere AGRA in November 2003 Technical calculation software for applying mathematics to engineering Nasdaq IPO in February 1993 Supplier of high precision reflective optical components and systems using a unique electroforming process Analytical Instrumentation Mobile content distribution platform and services Sold to Alcatel in 2004 Mobile payment solution Advance motion technology to build linear actuators that are silent low cost and low consumption Multi protocol Metro Ethernet solutions over SDH SONET Sold to Alcatel in March 2005 Music editing and publishing technology Sold to Coda Music Technology MakeMusic MMUS in October 2000 Acquired by Tokyo Electron TEL in March 2012 Noice cancellation solution Nasdaq IPO NCTI in October 1998 Integrated messaging platform as an outsourced solution to operators Sold to Phone com in October 2000 became Openwave OPWV Virtualization and provisioning platform for web and application hosting service providers Perigee Software Suite provides companies

    Original URL path: http://www.endeavourvision.com/portfolio-12-technology.htm (2016-04-25)
    Open archived version from archive

  • Investments in life sciences
    the lingering and debilitating lip and tongue numbness associated with local dental anesthesia OncoEthix is a drug development company dedicated to the development of compounds in oncology Indications of stroke and the related indications neuronal damage and thrombotic disease IPO on Frankfurt exchange PA8 in February 2005 PneumRx is developing and marketing minimally invasive therapeutic devices to treat emphysema patients Develop manufacture and market dental implant systems Sold participation in January 2006 Indication for pulmonary arterial hypertension PAH a life threatening disorder which severely compromises the function of the lungs and heart IPO on SWX in April 2000 Founded in April 2000 Discovery and development of small molecules active on novel G protein coupled receptors CHF38 Mio raised 60 employees Most advanced project Phase II sub arachnoid haemorrhage Acquired by Actelion ATLN in October 2003 Bind Therapeutics BIND is a biopharmaceutical company developing therapeutic targeted nanoparticles Medical Technology company developing a device to improve the care of type 2 diabetic patients Medical technology company with a device to treat morbid obese patients A gastric band restricts food intake and is remotely controlled by the medical doctor Company sold to Allergan AGN in February 2007 Discovery and development of SGDs small glycan drugs to provide the patient with safer and more efficient anti thrombotics Flamentera is developing monitoring tests for celiac disease Fully automated system for molecular biology diagnostics enabling easy DNA extraction and fast detection of bacteria Gynesonics designs and develops new and advanced technologies for improving women s health The company is focused on providing to women and the physicians who care for them an incision free uterus preserving option to treat symptomatic uterine fibroids The Sonata system combines intrauterine sonography with radio frequency ablation to precisely locate and ablate uterine fibroids associated with heavy menstrual symptoms in a simple same day procedure The system is cleared for sale in Europe CE Mark and the company is currently enrolling its US pivotal trial to evaluate safety and effectiveness Sonata offers the potential to reduce the number of more invasive procedures including hysterectomy and to offer women greater choices in the treatment of this very common condition Biomaterials and bioactives for chronic wounds and bone regeneration Lumavita is a biotech pharma company based in Basel Switzerland specialising in Woman s Health Molecular Partners is developing a novel class of binding proteins DARPins that will compete with monoclonal antibodies by addressing some of their weaknesses Neocutis is a spin off from the CHUV hospital in Lausanne focused on innovative dermatology skin care wound healing treatment and cosmetics Developing next generation treatment for brain aneurysms Covidien acquired Nfocus Neuromedical in February 2013 Mid stage specialty pharmaceutical company in dental market The Novalar product a vasodilatator rapidly reverses the lingering and debilitating lip and tongue numbness associated with local dental anesthesia Drug develpment company focused on the new therapies for immune related disorders and inflammation OncoEthix is a drug development company dedicated to the development of compounds in oncology Indications of stroke and

    Original URL path: http://www.endeavourvision.com/portfolio-17-life+sciences.htm (2016-04-25)
    Open archived version from archive

  • for entrepreneurs
    you need an investor that has experienced different market cycles and is proven to act wisely The true nature of your investors and their values are revealed during challenging times Knowing what teamwork can achieve Endeavour Vision attaches great importance to establishing genuine long lasting relationships with entrepreneurs before investing The tougher the situation the more you will appreciate having us on your side Endeavour Vision SA 2006 2016 Terms Conditions The partners have been very supportive of our approach and stepped in to add value when needed I would strongly recommend them as investors Didier Cowling Founder and CEO Kuros Biosurgery AG In preparing for our dual IPOs on the Nasdaq and Neuer Markt it was very important for SCM Microsystems to gain insight and access to the European investment scene This team helped SCM build the foundation for our successful offerings not only with capital but with sound guidance and value added services as well Robert Schneider founder and CEO SCM Microsystems Inc VC is about funding your project but it is more about extending your core team Thus it is about partnering with those who are great to work with and are team players Those who understand your business and embrace your vision Those who know how to challenge your execution and to bring value This is why I recommend Endeavour Vision team to entrepreneurs looking for funding Dr Georges Karam co Founder President CEO Sequans With Endeavour Vision we have been able to establish at fast speed the personal trust level needed and also come to terms very quick They are highly professional partners and support us in every possible manner Christian Lindner Co Founder and CEO Retailo AG We wanted a Venture Capital investor who was prepared to share our vision to create a global

    Original URL path: http://www.endeavourvision.com/info-20-6-entrepreneurs.htm (2016-04-25)
    Open archived version from archive

  • what we look for
    product service within parameters that are best in class and will allow them to reach profitability with the least amount of money 4 Ambitious agile and seasoned management team Ultimately Endeavour Vision invests in people the people behind the execution of a business plan who capture the opportunity inherent in a world class technology and a hyper growth global market We look for entrepreneurs and management teams who have the capacity the intelligence the drive and the passion to succeed in a highly competitive extremely volatile fast moving fast changing global market We expect nothing less than the best from our entrepreneurs and they should expect nothing less from us Endeavour Vision SA 2006 2016 Terms Conditions The partners have been very supportive of our approach and stepped in to add value when needed I would strongly recommend them as investors Didier Cowling Founder and CEO Kuros Biosurgery AG In preparing for our dual IPOs on the Nasdaq and Neuer Markt it was very important for SCM Microsystems to gain insight and access to the European investment scene This team helped SCM build the foundation for our successful offerings not only with capital but with sound guidance and value added services as well Robert Schneider founder and CEO SCM Microsystems Inc VC is about funding your project but it is more about extending your core team Thus it is about partnering with those who are great to work with and are team players Those who understand your business and embrace your vision Those who know how to challenge your execution and to bring value This is why I recommend Endeavour Vision team to entrepreneurs looking for funding Dr Georges Karam co Founder President CEO Sequans With Endeavour Vision we have been able to establish at fast speed the personal trust

    Original URL path: http://www.endeavourvision.com/info-21-7-what+we+look+for.htm (2016-04-25)
    Open archived version from archive

  • questions & answers
    a decision to invest we have done so unanimously and the full force and effect of the Partnership s resources are at your disposal We invest money but deliver value How is the Due Diligence process carried out We typically have four phases in our evaluation process 1 Initial Screening Review of Business Plan call conference initial meeting with management 2 Business Evaluation Bottom up analysis of plan market analysis examination of current future customers product tests technology assessment verification of differentiating factors review of key issues Interview with the whole team with early investors if any customer strategic partners interviews etc Evaluation of risk return profile of investment and issuing of Letter of Intent LOI 3 Due Diligence In depth review of all aspects of company references checks review of IP legal contracts and leads meeting with company board set up of investment syndicate and potential board members conclusion of terms The due diligence process itself consists of at least the following Management assessment Face to face meetings between your company management and our partners are absolutely critical This allows us to understand and assess your team and to get a sense of that indefinable but critical quality of chemistry These meetings should also be your opportunity to assess us whether you think that we can truly add value to your business whether our thinking is aligned with yours and whether you feel comfortable working closely with us on your future success Typically we will have five or more meetings with your management team either as a group or on a one to one basis to determine the above issues Technical Due Diligence This is either conducted directly by Endeavour Vision or in some cases with the assistance of outside experts for example to check the intellectual property or the country specific legal aspects While technical sufficiency is always important in our investments technical superiority does not alone justify an investment In our experience the world is full of technically superior solutions that never achieve market success because of management s inability to conceive develop and execute a winning strategy True success only results from a combination of excellent management a large and or fast growing market superior technology perfect timing dogged and unwavering perseverance All can be understood and managed Financial review We spend a lot of our due diligence time to understand and agree on your business model and its underlying market assumptions Financial projections are important but only after understanding the assumed model market conditions pertinent predictions and management s ability to execute an intelligent and realistic strategy successfully 4 Closing Financial and legal audit agreement on board rules and company reporting system signing of contracts and payment How much will you typically invest in a company and do you require a certain ownership percentage Endeavour Vision seeks to invest up to EUR 10m in a portfolio company over the life of the investment and through subsequent rounds of investment We typically invest follow on rounds

    Original URL path: http://www.endeavourvision.com/info-22-8-questions+and+answers.htm (2016-04-25)
    Open archived version from archive

  • Endeavour Vision - Portfolio
    for a constructive relationship with management in an effort to succeed Mike Wall CEO Amplidata In preparing for our dual IPOs on the Nasdaq and Neuer Markt it was very important for SCM Microsystems to gain insight and access to the European investment scene This team helped SCM build the foundation for our successful offerings not only with capital but with sound guidance and value added services as well Robert Schneider founder and CEO SCM Microsystems Inc VC is about funding your project but it is more about extending your core team Thus it is about partnering with those who are great to work with and are team players Those who understand your business and embrace your vision Those who know how to challenge your execution and to bring value This is why I recommend Endeavour Vision team to entrepreneurs looking for funding Dr Georges Karam co Founder President CEO Sequans The partners have been very supportive of our approach and stepped in to add value when needed I would strongly recommend them as investors Didier Cowling Founder and CEO Kuros Biosurgery AG Endeavour Vision SA 2006 2016 Terms Conditions The partners have been very supportive of our approach and stepped in to add value when needed I would strongly recommend them as investors Didier Cowling Founder and CEO Kuros Biosurgery AG In preparing for our dual IPOs on the Nasdaq and Neuer Markt it was very important for SCM Microsystems to gain insight and access to the European investment scene This team helped SCM build the foundation for our successful offerings not only with capital but with sound guidance and value added services as well Robert Schneider founder and CEO SCM Microsystems Inc VC is about funding your project but it is more about extending your core team Thus

    Original URL path: http://www.endeavourvision.com/info-24-10-quotes.htm (2016-04-25)
    Open archived version from archive

  • Recent news: Endeavour establishes largest medtech fund in Europe at EUR 250m
    Genetics Becomes the First European Company to Obtain CE IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing August 19 2014 New Dundee studio for Kobojo July 22 2014 CommProve strengthen its commitment with Cell C in Africa July 8 2014 Sophia Genetics raises Series B round led by Invoke Capital July 1 2014 Stage 3 Phase 2 study of DARPin abicipar pegol previously MP0112 supports progressing to phase III development program June 19 2014 Bind Therapeutics enters nanomedicine collaboration with Swiss drug giant June 12 2014 Amplidata Expands Leadership Team to Support Growth June 11 2014 Amplidata Reaches New Heights In Storage Scalability and Manageability with Himalaya June 11 2014 Verizon Adopts Amplidata s New Himalaya Storage Architecture for Cloud Storage Service April 29 2014 Amplidata and Avere Systems Redefine The Economics Of Massively Scalable High Performance NAS Storage April 25 2014 Mutants Genetic Gladiators Brings Monster Battles to iOS Android Platforms April 10 2014 CommProve confirm its strong presence in LATAM April 10 2014 CeQur Appoints Douglas Lawrence Chief Executive Officer April 8 2014 Epigenetic Cancer Therapy Clears Phase I March 24 2014 Amplidata Secures 11M to Drive Next Phase of Growth March 5 2014 Diabetes Care Publishes Data Demonstrating PaQ Insulin Delivery Device Could Help People with Type 2 Diabetes Overcome Barriers to Insulin Adherence and Improve Clinical Outcomes January 22 2014 Sakura Internet Cloud Datacenter Deploys Amplidata Object Store for Cloud Archiving Backup and Content Delivery Services January 8 2014 CeQur to Present at the 32nd Annual J P Morgan Healthcare Conference December 4 2013 Roche and Molecular Partners enter into alliance to develop new cancer treatments December 2 2013 Blackhawk Network Acquires Germany Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy November 19 2013 Spartoo test driver of the European Google Trusted Store program November 13 2013 Amplidata Named a Leader in IDC MarketScape for Object Based Scale Out Storage October 28 2013 Symetis Announces a Symbolic Milestone the 1000th Patient Implanted with ACURATE TA October 28 2013 French Cost Effectiveness Trial of PneumRx RePneu LVR Coil Fully Enrolled in Record Time October 8 2013 CommProve Announces New Mobile Operator Win in Asia September 26 2013 Symetis and Endoluminal Sciences enter into a license agreement to develop 3rd generation TAVI September 24 2013 Data Demonstrating Potential Benefits of Simple Insulin Delivery Device Presented at European Association for the Study of Diabetes Annual Meeting September 19 2013 BIND Therapeutics Announces Pricing of Initial Public Offering September 18 2013 CommProve Wins 2 7M New Business in Africa September 9 2013 CeQur SA Closes 27 Million Series B Financing August 27 2013 BIND Recognized by the World Economic Forum as a Technology Pioneer August 19 2013 BIND Doses First Patient in a Phase 2 Clinical Study of BIND 014 in Prostate Cancer August 12 2013 BIND Therapeutics Files Registration Statement for Proposed Initial Public Offering August 12 2013 Symetis announces successful first time implantation of i ts ACURATE TA

    Original URL path: http://www.endeavourvision.com/news-m25-n0-news.htm (2016-04-25)
    Open archived version from archive



  •